Implicity Appoints Jon Hunt, PhD, as Chief Commercial Officer
Hunt joins the company from HeartBeam.
Jon Hunt, PhD, is joining Implicity as chief commercial officer.
Previously, Hunt worked for HeartBeam, a cardiac technology company, as an executive vice president and chief business officer. He has worked in the cardiovascular device industry for nearly 40 years.
In a press release, CEO and co-founder of Implicity Arnaud Rosier, MD, PhD, said, “Having an executive of Jon's caliber and experience is key to achieving our goal of becoming the leader in remote cardiac monitoring in the U.S. market. Jon brings extensive experience in the CRM/EP market and a proven track record of scaling startup companies and building commercial teams. We look forward to his guidance and expertise as we continue to build on our successes and provide healthcare professionals nationwide with more effective solutions for managing heart disease.”.
Implicity is a digital medtech software company that produces a platform that collects and standardizes data from a variety of implantable cardiac devices from different companies.
Source
(Sept. 27, 2023); Implicity; Implicity Expands Senior Leadership Team with New US Chief Commercial Officer; https://www.prnewswire.com/news-releases/implicity-expands-senior-leadership-team-with-new-us-chief-commercial-officer-301939282.html
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.
